Childhood Cancer

You are here

GENOME ORIGAMI: Refolding Aberrant Chromosome 3D Structure for Treating NUT Carcinoma

Baylor College of Medicine
Kyle Eagen, PhD
Grant Type: 
R Accelerated Award Grants
Year Awarded: 
Type of Childhood Cancer: 
General Pediatric Cancer
Project Description: 

NUT carcinoma is an aggressive cancer with a devasting prognosis. It is almost always fatal, with survival measured in months to – at best – two years. This cancer can be diagnosed in children of all ages – from infants to teenagers. NUT carcinoma tumors most often occur in the chest, but can also be found in the head, neck, bones, or soft tissue. NUT carcinoma tumors are caused by a genetic event in which two chromosomes break in half, swap halves, and then fuse back together. This results in a gene fusion that adds a segment of the protein “NUT” to a segment of the protein “BRD4”. This BRD4-NUT fusion protein changes gene regulation. Proper gene folding inside a healthy cell determines if genes are turned on or turned off. We recently discovered that BRD4-NUT performs “genome origami”: it misfolds the DNA inside a cancer cell, resulting in inappropriate gene expression.

Project Goals:

When we discovered that BRD4-NUT misfolds DNA, we also discovered that we could use a drug to refold the DNA back into its proper shape. This is an entirely new concept in how to treat NUT carcinoma and other pediatric cancers in which DNA folding is disrupted, such as Ewing sarcoma and leukemias. Unfortunately, the first class of drugs that block BRD4-NUT from improperly folding chromosomes are too toxic for use in patients. The goal of this project is to identify proteins that collaborate with BRD4-NUT to misfold DNA. By targeting the collaborating proteins, we have a fresh avenue to identify an entirely new class of drugs that are safe and effective for treating patients with NUT carcinoma.